Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children Sacarlal J et al. - The results show evidence that RTS,S/AS02A maintained protection during the 45-month surveillance period, and they highlight the feasibility of developing an effective vaccine against malaria. In combination with other malaria-control measures, such a vaccine could greatly contribute to reducing the intolerable global burden of this disease. [more...]
